Market Research & Insights
Clarivate patient centricity report underscores need for evolution from selling products to building relationships
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release […]
MoreMarket Research & Insights
The future of the generics landscape: Key branded drugs losing exclusivity in 2021 and beyond
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the launch of […]
MoreMarket Research & Insights
Patient centricity has long been at the heart of medical innovation, but today shapes its future
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the launch of […]
MoreMarket Research & Insights
Clarivate forecasts nearly 70% of Asia Pacific, North American and European adult populations will be vaccinated for COVID-19 by September 2021
A new report analyses how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across […]
MoreMarket Research & Insights
2021 outlook for pharma mergers and acquisitions
Market Research & Insights: A recent PwC report indicated an optimistic 2021 for the pharmaceutical and life sciences (PLS) sector […]
MoreMarket Research & Insights
What high-performing MedTech companies are doing differently
Market Research & Insights: Innovation and product development (I&PD) in the MedTech sector is costly. A strong I&PD strategy can help […]
MoreMarket Research & Insights
New report identifies skills priorities for future workforce of Pharma, MedTech and Biotech
Market Research & Insights
MedTech leaders prioritise innovation and technology
Please log in to Health Industry Hub to view this content in the Market Research & Insights menu.
Market Research & Insights
Workforce gaps in Australian MedTech, Pharma, Biotech and digital health sectors
Australia’s medical technology, biotechnology, pharmaceutical and digital health sector supports approximately 70,000 Australian jobs and contributed more than $5 billion […]
MoreMarket Research & Insights
New report highlights impact of COVID-19 on cancer screening
Please log in to Health Industry Hub to view this content in the Medical sub-menu.
Recent Posts in Pharma, MedTech & Biotech
Is Australia any closer to the negotiation table on U.S. medicines pricing?
August 15, 2025
in News - Pharmaceuticals
Balancing the scales: Why are we missing the mark on diabetes?
August 15, 2025
in Medical and Science
Bridging the bench and boardroom: Rethinking innovation in aggressive breast cancer
August 15, 2025
in Medical and Science
Blood biomarker pinpoints patients for LuPSMA therapy in prostate cancer
August 13, 2025
in News - Pharmaceuticals
Australia’s first robotic system delivers complex surgery with just one tiny cut
August 13, 2025
in News - MedTech & Diagnostics
Can AI bridge HTA workforce gaps and budget black hole?
August 13, 2025
in News - Pharmaceuticals
Amgen’s race to recharge the pulse of R&D: National Science Week
August 12, 2025
in Medical and Science
Leadership shift sets Biogen ANZ on course for next-phase growth
August 12, 2025
in Leadership & Management
Follow Us
Partner with us
News - Pharmaceuticals
Is Australia any closer to the negotiation table on U.S. medicines pricing?
The U.S. tariff debate, alongside pressure for a ‘Most-Favored-Nation’ pricing model, continues to cast uncertainty over government policy and industry […]
MoreMedical and Science
Balancing the scales: Why are we missing the mark on diabetes?
As Australia marks National Science Week, two of the nation’s leading voices in diabetes research and policy sit down to […]
MoreMedical and Science
Bridging the bench and boardroom: Rethinking innovation in aggressive breast cancer
Coinciding with National Science Week podcast, Andrew Parry, Associate Director of Global Medical Strategy & Operations at Gilead Sciences and […]
MoreNews - Pharmaceuticals
Blood biomarker pinpoints patients for LuPSMA therapy in prostate cancer
A blood test is set to predict which advanced prostate cancer patients will respond to the radioligand therapy 177-Lutetium prostate-specific […]
More